Torque Pharma collaborates with 'Jatt and Juliet 3' for an ad film that ...

3 days ago

Torque Pharma collaborates with ‘Jatt and Juliet 3’ for an ad film that merges healthcare and entertainment

Mumbai: Torque Pharma is looking to leverage synergy between healthcare and entertainment to push its cough syrup. This is being done through an ad film in collaboration with ‘Jatt and Juliet 3’ starring Diljit Dosanjh and Neeru Bajwa. The ad is being amplified across digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn

The ad will also run in 119 Single Screen Cinema Theatres in Punjab, Haryana, Delhi NCR, HP and J&K. aired on MYFM & Big FM Radio Stations in Punjab, Haryana & Chandigarh & also promoted in Print Media in Punjab, Haryana, Chandigarh & few parts of UP. The clip will be aired three weeks before and three weeks after the movie’s launch. The launch took place on 27 June, 2024 (Thursday)

The aim is to create a connection that binds the audience together and enhances brand recall for the cough syrup.

Abhay Iqbal Singh Bedi, director, Torque Pharma said, “We are thrilled to collaborate with ‘Jatt and Juliet 3,’ a film that has a wide set of fanbase, much like Torex Cough Syrup that embodies health and wellness. This partnership enhances our brand presence while reaffirming our commitment to delivering effective cough relief, allowing our customers to savour life’s moments free from the discomfort of a cough. We are confident that this co-branding initiative with ‘Jatt & Juliet 3’ will forge a deep and lasting connection with audiences.”

“We’re excited to partner with Torex Pharmaceuticals for ‘Jatt & Juliet 3.’ This collaboration brings together two trusted brands to deliver an unforgettable experience to our audience. We look forward to a successful journey together and can’t wait for everyone to experience the magic of ‘Jatt & Juliet 3’ in theatres.” said Manmord Singh Sidhu, MD White Hill Studios and the producer of the film.

Watch the ad film here:

Read more
Similar news
This week's most popular news